Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for ...

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with ...

A company that has Donald Trump Jr. on its board touted in a press release a new “initiative” to help pharmaceutical ...

Ministers are preparing to boost NHS spending on US drugs in a race to avoid a future tariff hit from Donald Trump.

Tesla’s board is giving Chief Executive Elon Musk a $23.7 billion stock award —so long as he stays focused on the company.

Pfizer Inc. (NYSE: PFE) delivered a stronger-than-anticipated second-quarter performance, beating analyst estimates and ...

The dividend yield investors could receive from Pfizer stock has risen from about 3% in early 2022 to 7% when the market ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

AI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...

President Trump threatened 250% tariffs on pharma; Pfizer CEO contacted Trump about most favored nation pricing; Ex-X CEO joins eMed.